25746133|t|Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors.
25746133|a|Fatty acid amide hydrolase (FAAH) is the principal responsible for the termination of anandamide signaling, a major actor of the endocannabinoid system. The indirect stimulation of endocannabinoid responses achieved through FAAH inhibition can represent a valid pharmacological strategy for the treatment of neurodegenerative and neuroinflammatory diseases such as multiple sclerosis, Alzheimer's, Huntington's, and Parkinson's diseases, as well as rheumatoid arthritis, gastrointestinal inflammatory states, anxiety, and other pathologies. With the aim of identifying new noncovalent FAAH inhibitors and also experimentally validating the reliability of the recently reported consensus docking approach, we filtered a commercial database of about 1 million compounds by using a mixed FLAP (fingerprints for ligands and proteins) consensus docking approach. Enzymatic assays showed FAAH inhibitory activity and selectivity versus MAGL for 8 out of the 10 top ranked compounds, with IC50 values in the low micromolar range for the two most active compounds. These results demonstrate the reliability of the virtual screening strategy and constitute an experimental validation of the consensus docking approach. Moreover, the two most active compounds described could represent promising leads for the development of high potent noncovalent FAAH inhibitors. 
25746133	85	111	fatty acid amide hydrolase	Gene	2166
25746133	124	150	Fatty acid amide hydrolase	Gene	2166
25746133	152	156	FAAH	Gene	2166
25746133	210	220	anandamide	Chemical	MESH:C078814
25746133	253	268	endocannabinoid	Chemical	MESH:D063388
25746133	305	320	endocannabinoid	Chemical	MESH:D063388
25746133	348	352	FAAH	Gene	2166
25746133	432	449	neurodegenerative	Disease	MESH:D019636
25746133	454	480	neuroinflammatory diseases	Disease	MESH:D000090862
25746133	489	507	multiple sclerosis	Disease	MESH:D009103
25746133	509	520	Alzheimer's	Disease	MESH:D000544
25746133	522	534	Huntington's	Disease	MESH:D006816
25746133	540	560	Parkinson's diseases	Disease	MESH:D010300
25746133	573	593	rheumatoid arthritis	Disease	MESH:D001172
25746133	595	631	gastrointestinal inflammatory states	Disease	MESH:D005767
25746133	633	640	anxiety	Disease	MESH:D001007
25746133	709	713	FAAH	Gene	2166
25746133	1006	1010	FAAH	Gene	2166
25746133	1054	1058	MAGL	Gene	11343
25746133	1463	1467	FAAH	Gene	2166
25746133	Association	MESH:C078814	2166
25746133	Association	MESH:D009103	2166
25746133	Association	MESH:D063388	MESH:D019636
25746133	Association	MESH:D005767	2166
25746133	Association	MESH:D063388	MESH:D005767
25746133	Association	MESH:D006816	2166
25746133	Association	MESH:C078814	MESH:D063388
25746133	Association	MESH:D001172	2166
25746133	Association	MESH:D063388	MESH:D000090862
25746133	Association	MESH:D000544	2166
25746133	Association	MESH:D063388	MESH:D000544
25746133	Association	MESH:D063388	MESH:D006816
25746133	Association	MESH:D063388	MESH:D001172
25746133	Association	MESH:D063388	MESH:D001007
25746133	Association	MESH:D063388	MESH:D009103
25746133	Association	MESH:D063388	2166
25746133	Association	MESH:D019636	2166
25746133	Negative_Correlation	11343	2166
25746133	Association	MESH:D063388	MESH:D010300
25746133	Association	MESH:D010300	2166
25746133	Association	MESH:D001007	2166
25746133	Association	MESH:D000090862	2166

